RSS   Newsletter   Contact   Advertise with us

AcelRx names VP of commercial strategy

Share on Twitter Share on LinkedIn
Staff writer | Redwood City, Ca., USA | October 2, 2015
AcelRxOctober 2, 2015, Redwood City, Ca., USA - AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, announced the appointment of Gina Ford to the role of vice president of commercial strategy.
Ms. Ford has worked with AcelRx as a consultant from 2013 to the present and has been instrumental in the development of a commercial strategy for Zalviso (sufentanil sublingual tablet system), a drug-device combination product for the management of acute moderate-to-severe post-operative pain in adult patients.

Before joining the AcelRx management team, Ms. Ford was principal and sole proprietor of One Joule, a commercial strategy consulting company.

Before founding One Joule, Ms. Ford was president of Accesia, a wholly owned subsidiary of Patient Services, Inc., and held several leadership roles at Ipsen, a global pharmaceutical company focusing on neurology, endocrinology and urology-oncology.

Ms. Ford received a Bachelor of Science in pharmacy from Southwestern Oklahoma State University and a Master of Business Administration from Capella University.